Patients with a history of severe cardiovascular disease, including heart rhythm disorders, should avoid nilotinib. It is also contraindicated in patients with hypokalemia and hypomagnesemia, as these conditions can increase the risk of QT prolongation. Pregnant women and those planning to become pregnant should also avoid nilotinib due to potential risks to the fetus.
